TY  - CHAP
M1  - Book, Section
TI  - Chapter 10. Understanding the Use of Pharmacoeconomic Analysis to Assess the Economic Impact of Pharmacogenomic Testing
A1  - Bounthavong, Mark
A1  - Nguyen, Christine M.
A1  - Mendes, Margaret
A2  - Bertino, Joseph S.
A2  - DeVane, C. Lindsay
A2  - Fuhr, Uwe
A2  - Kashuba, Angela D.
A2  - Ma, Joseph D.
Y1  - 2013
N1  - 
T2  - Pharmacogenomics: An Introduction and Clinical Perspective
AB  - Define  the  different  elements  of  pharmacoeconomic  analysis:  costs,  benefits,  perspective,  cost-effectiveness  plane,  ECHO  model,  utility  weights  and  quality-adjusted  life  years  (QALYS),  and  discounting.Identify  the  different  pharmacoeconomic  analyses  available:  cost-minimization  analysis,  cost–benefit  analysis,  cost-effectiveness  analysis,  and  cost–utility  analysis.Know  the  elements  of  a  decision  model:  decision  nodes,  chance  nodes,  and  terminal  nodes.Identify  and  interpret  the  results  of  a  one-way  sensitivity  analysis,  two-way  sensitivity  analysis,  and  probabilistic  sensitivity  analysis,  and  cost-effectiveness  acceptability  curve.Determine  why  pharmacoeconomics  is  needed  when  utilizing  pharmacogenomics  in  clinical  practice.  
SN  - 
PB  - The McGraw-Hill Companies
CY  - New York, NY
Y2  - 2024/04/19
UR  - accesspharmacy.mhmedical.com/content.aspx?aid=56876502
ER  -